Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (47)
NICE advice (7)
Quality standard (1)
Guidance programme
Guidance programme
Cancer service guidelines (1)
Clinical guidelines (3)
Diagnostics guidance (2)
Interventional procedures guidance (5)
Medical technologies guidance (1)
NICE guidelines (4)
Technology appraisal guidance (35)
Apply filters
Showing 1 to 10 of 47
Sort by
Date
Title
Apply sorting
breast cancer
Remove breast cancer filter
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Tumour profiling tests to guide adjuvant chemotherapy decisions in early
breast cancer
DG58
9 May 2024
9 May 2024
Talazoparib for treating HER2-negative advanced
breast cancer
with germline BRCA mutations
TA952
21 February 2024
21 February 2024
Early and locally advanced
breast cancer
: diagnosis and management
NG101
18 July 2018
16 January 2024
Familial
breast cancer
: classification, care and managing
breast cancer
and related risks in people with a family history of
breast cancer
CG164
25 June 2013
14 November 2023
Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early
breast cancer
after chemotherapy
TA886
10 May 2023
10 May 2023
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic
breast cancer
after 1 or more anti-HER2 treatments
TA862
1 February 2023
1 February 2023
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced
breast cancer
TA851
14 December 2022
14 December 2022
Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced
breast cancer
after endocrine therapy
TA836
26 October 2022
26 October 2022
Magtrace and Sentimag system for locating sentinel lymph nodes for
breast cancer
MTG72
5 October 2022
5 October 2022
Sacituzumab govitecan for treating unresectable triple-negative advanced
breast cancer
after 2 or more therapies
TA819
17 August 2022
17 August 2022
Current page
1
2
3
4
5
Page
1
of
5
Next page
Results per page
10
25
50
All
Back to top